Publications by authors named "Yoshiki Yui"

Claim this Profile
E
Erratum: Author Correction: Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.
Yoshiki Yui

NPJ Regen Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.
Yoshiki Yui

NPJ Regen Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo absorption and metabolism of leptosperin and methyl syringate, abundantly present in manuka honey.
Akari Ishisaka, Shinichi Ikushiro, Mie Takeuchi, Yukako Araki, Maki Juri, Yui Yoshiki

Mol Nutr Food Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a Monoclonal Antibody against Syringate Derivatives: Application of Immunochemical Detection of Methyl Syringate in Honey.
Yoji Kato, Rie Fujinaka, Maki Juri, Yui Yoshiki, Akari Ishisaka

J Agric Food Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questions Surrounding iPS Cells in Japan.
Yoshiki Yui

Int J Stem Cells· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of misconduct in clinical trials in Japan.
Yoshiki Yui

Lancet· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.
Yoshiki Yui, Kazuhisa Kodama, Atsushi Hirayama, Saichi Hosoda, Chuichi Kawai

J Clin Hypertens (Greenwich)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns about the Jikei Heart Study.
Yoshiki Yui

Lancet· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
Yoshiki Yui, Kazuhisa Kodama, Atsushi Hirayama, Ryosuke Nishio, Yoshitaka Iwanaga, Natsuko Yui

J Hypertens· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[JMIC-B study and its sub-analyses: effect of nifedipine in Japanese hypertensive patients with coronary artery disease].
Yoshiki Yui

Drugs· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
Yoshiki Yui, Eiji Shinoda, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi

J Hypertens· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unstable angina and non-ST elevation acute coronary syndrome: epidemiology and current management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee).
Yoshiki Yui, Atsushi Hirayama, Hiroshi Nonogi, Kazuo Kimura, Kazuhisa Kodama

Circ J· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
Eiji Shinoda, Yoshiki Yui, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi

Hypertension· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.
Yoshiki Yui, Tetsuya Sumiyoshi, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi

Hypertens Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.
Yoshiki Yui, Tetsuya Sumiyoshi, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi

Hypertens Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).
Atsushi Hirayama, Kazuhisa Kodama, Yoshiki Yui, Hiroshi Nonogi, Tetsuya Sumiyoshi

Am J Cardiol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
Hiroaki Shimokawa, Katsuhiko Hiramori, Hiroyuki Iinuma, Saichi Hosoda, Hiroshi Kishida, Yoshiki Yui

J Cardiovasc Pharmacol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats.
Yoshihito Takimoto, Takeshi Aoyama, Koichi Tanaka, Reiko Keyamura, Yoshiki Yui

Circulation· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis